XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 120 Months Ended
Jan. 31, 2022
Jan. 27, 2020
Jun. 24, 2019
Jun. 07, 2018
Jul. 14, 2006
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2028
Jan. 05, 2022
Dec. 31, 2021
Mar. 31, 2018
Subsidiary or Equity Method Investee [Line Items]                      
Preferred stock, shares issued           0       0  
Preferred stock, shares outstanding (in shares)           0       0  
Shares granted with respect to maximum fixed amount equal, percentage       20.00% 20.00%            
Options granted under original plan exercisable period         10 years            
Maximum number of common shares reserved for issuance (in shares)       5,686,097              
Shares issuable upon exercise of stock options)                     3,686,097
Number of shares available for grant           978,461       952,632  
Proceeds from stock options exercised           $ 12          
Expected average life of options           5 years 11 months 4 days 6 years 25 days        
Unamortized compensation expense related to unvested options           $ 31,448          
Remaining unamortized compensation expense, weighted-average period           1 year 9 months 3 days          
Share-based compensation arrangement by share-based payment award, stock plan offering period           6 months          
Total amount contributed by ESPP participants           $ 475       $ 1,243  
Forecast                      
Subsidiary or Equity Method Investee [Line Items]                      
Maximum number of common shares reserved for issuance increase in percentage               4.00%      
Inducement Plan                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of common shares reserved for issuance                 750,000    
Restricted Share Units (RSUs)                      
Subsidiary or Equity Method Investee [Line Items]                      
Shares available for issuance under the Original Plan exercisable period           3 years          
Award vesting rights, percentage           33.00%          
Nonvested award, cost not yet recognized, amount           $ 2,678          
Nonvested award, cost not yet recognized, period for recognition           1 year 4 months 2 days          
Compensation charge           $ 604 $ 606        
Employees Stock Purchase Plan                      
Subsidiary or Equity Method Investee [Line Items]                      
Compensation charge           $ 183 $ 269        
Maximum eligible employees contribution under ESPP           15.00%          
Purchase of shares under ESPP, maximum limit for each employee           $ 25          
Offering                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of shares issued (in shares) 11,035,000                    
Sale of stock (usd per share) $ 8.00                    
Pre-funded warrants 3,340,000                    
Warrants issued price (in dollars per share) $ 7.9999 $ 46.4999 $ 17.9999                
Net proceeds from issuance $ 107,534                    
Pre funded warrants issued in lieu of common shares to underwriters (in shares)   1,075,271 4,166,690                
Exercise price of warrants (usd per share) $ 0.0001 $ 0.0001 $ 0.0001                
Over-Allotment Option                      
Subsidiary or Equity Method Investee [Line Items]                      
Number of shares issued (in shares) 1,875,000